Ministry of health pharmaceutical services detailed GMP transformation is expected to be supported
2018-07-13
In the pharmaceutical industry, cheap drugs have always been considered to have small share and less profit. In the context of the business environment, it is completely understandable that the business community has not expressed any positive attitude and responsibility in the context of the business environment.
But yesterday (December 28th), the Central People's broadcasting station, in a report on the shortage of cheap drugs, interviewed Miao Wei, the Minister of the Ministry of industry and information, and the Minister of Miao, who deplored the shortage of cheap drugs.
Miao Wei believes that the shortage of cheap drugs is a problem at the supply side, and the state has already been concerned about this problem. For the "country" referred to here, mic366 believes that, in theory, it should include the pharmacy, the health plan, the work letter and the reform, which also shows that the work letter has been prepared in this respect.
We know that there is a consumer goods department under the Ministry of industry and information. There is a medical department under the Department. The main responsibility of the Department is to undertake the management of the pharmaceutical industry, including the management of the support project of Chinese medicine production and the management of the national drug reserve.
Since October this year, the official home page of the consumer goods division has begun to report on "cheap drug research", which has not been reported in the past three or four years.
According to the report of the official home page of the consumer goods department, it was first in October 11th of this year. The part of the Party group and chief engineer of the consumer goods department, Zhu Hongren, investigated the supply of the shortage drug.
In view of the shortage of thyroid drug methimidazole in some areas, the Minister of Miao Wei approved to solve the problem of the shortage of low price drugs in clinical practice as a concrete action to promote the party's mass line education activities and change the edge of the border.
To this end, the Department of consumer goods industry of the Ministry of industry and information technology has conducted research with the National Health Planning Commission, the development and Reform Commission, the Beijing Municipal Commission for information and the food and Drug Administration Bureau and other departments, and take measures to continue the validity period of the GMP certificate and reform the key equipment, and quickly organize the production of 120 million tablets of methimazole to put into the market.
In the investigation, Zhu Hongren pointed out that it is necessary to strengthen the overall coordination of various departments, study and establish a long-term mechanism to ensure the supply of low-cost drugs.
According to the Party group and the Minister of the Ministry of industry and information, the Minister of Miao Wei, "to be truly satisfied with the masses and to be the standard, to earnestly help solve the problem of the people in urgent need of low price drugs", a month ago in November 29th, the leader of the consumer goods department investigated the production and supply of methimazole in pharmaceutical enterprises and drugstores, and expressed the protection of methyl mercapto. The production and supply of small clinical essential basic drugs, such as azole, is a specific action to solve the urgent needs of the people, and effective measures should be taken to ensure the supply of drugs.
Support of Chinese medicinal materials project
The Ministry of industry's support for Chinese medicinal materials is based on information enquiries from the economic and Trade Commission in 2005, and has been at least 8 years since then. The national central government financial support for Chinese medicine project funds, in 2010 to 25 million yuan, in 2011 to 125 million yuan, in 2012 to 135 million yuan, in 2013, the specific amount of support should be more than in 2012. If each year supports sixty or seventy support projects, the average support for each project will be relatively large. It also indicates that the Ministry of industry and commerce is confident and determined to support the Chinese herbal medicine industry.
Mic366 learned that the Ministry of the Ministry of industry and information every year of the "Chinese medicine production support project declaration guide" release time is expected in the first half of February and March, after the "guide" is published, generally have more than a month to organize the declaration. For example, in 2013, the guide time is 6 days before the Spring Festival in February 4th, and the deadline for the declaration is March 31st. Although the time seems to be 55 days, the time of the Spring Festival is busy, and the real time can be estimated for one month.
There are three main types of support projects in the Ministry of work: one is the construction project of commonly used crude drug production base; two is the construction of the production base of endangered rare medicinal materials; and three is the supply guarantee platform for Chinese medicinal materials.
This year, it will be the end of the year, the work department to support the Chinese medicine project, Mic366 reminds industry enterprises or institutions, should pay attention to the previous years, in the opinion of their initial conditions of declaration, as early as possible to arrange the relevant personnel to prepare.
GMP technical reform support will have funds to support?
I have not seen this problem on file. But it does not mean that it is not or is not ready to have it.
First of all, in a big way, the Ministry of Industry and Information Technology every year in the enterprise technical reform support funds are available, of course, this is for all industries. In July, Guangdong Zhengyuan China tea Bioengineering Co., Ltd., the GMP workshop technical transformation project of healthy nutrition food, is a new GMP workshop which meets the requirements of the new edition of the standard of the quality management of drug production (revised in 2010), and is equipped with a complete set of independent research and development of the effective component extraction system of the constant low temperature plant. The company applied for the 1 million 200 thousand yuan policy support of the Ministry of industry's "industrial small and medium-sized enterprise technological transformation project".
Pharmaceutical industry is not small, in the industry as a whole can get such technical reform support should be less, and then combined with GMP transformation, should be less. But we should also be aware of the following information:
In January 8, 2013, the four ministries and commissions, such as the State Drug Administration Bureau, the State Development and Reform Commission, the Ministry of industry and information, and the Ministry of health, officially issued the notice on speeding up the implementation of new revised drug production quality management standards to promote the upgrading of the pharmaceutical industry. In this notice, we refer to "support enterprise GMP transformation project". GMP is the pharmaceutical industry, so this support can be understood as mainly the Ministry of industry and commerce.
